Monotherapy or co-administered w/ HMG-CoA reductase inhibitor, as adjunctive therapy to diet in patients w/ primary (heterozygous familial & non-familial) hypercholesterolaemia who are not appropriately controlled w/ statin alone. Co-administered w/ a statin, as adjunctive therapy to diet in patients w/ homozygous familial hypercholesterolaemia.